Lynda Vrooman, MD

Trials

Studies that name Lynda Vrooman, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:31 UTC. Open this list on ClinicalTrials.gov

• N/A
  NCT02355340 · Bone Mineral Density Status in Pediatric and Adolescent Survivors of Childhood Cancer With History of Bone Fracture

  Dana-Farber Cancer Institute · completed · Bone Mineral Density, Childhood Cancer Survivors · principal investigator
• Ph2
  NCT01643408 · A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy

  Jazz Pharmaceuticals · completed · Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma · principal investigator
• Ph3
  NCT00400946 · 05-001: Treatment of Acute Lymphoblastic Leukemia in Children

  Dana-Farber Cancer Institute · completed · Drug/Agent Toxicity by Tissue/Organ, Leukemia · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 10:31 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• P01CA068484
  RePORTER returned no project for this number; it is shown as the registry gives it.
  Named on NCT00400946
• Administrative Core
  P30CA006516 · NCI · DANA-FARBER CANCER INST · PI Deborah J Goff · fiscal years 2018 to 2026
  Named on NCT00400946